Guardant Health, Inc. (Nasdaq: GH) today announced the pricing of its offering of $1,000,000,000 aggregate principal amount of 0% convertible senior notes due 2027 (the "notes") in a private offering to qualified institutional buyers pursuant to Rule … Guardant Health, Inc. Common Stock (GH) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading … The company's average rating score is 3.00, and is based on 8 buy ratings, no hold ratings, and no sell ratings. Full Company Report for GH. The average price target is $113.00, with a high forecast of $130.00 and a low forecast of $100.00. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. GH's price/sales ratio is 46.45; that's higher than the P/S ratio of 95.01% of US stocks. Get short term trading ideas from the MarketBeat Idea Engine. Since then, GH stock has increased by 94.2% and is now trading at $122.26. The P/E ratio of Guardant Health is -64.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. This investing legend has flipped options trading upside down... making money on 85% of his trades. It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. If you experience any issues with this process, please contact us for further … Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. Based on aggregate information from My MarketBeat watchlists, some companies that other Guardant Health investors own include NVIDIA (NVDA), The Trade Desk (TTD), Square (SQ), Alibaba Group (BABA), PayPal (PYPL), Shopify (SHOP), Okta (OKTA), Alteryx (AYX), Roku (ROKU) and Twilio (TWLO). Follow My #1 Rule Instead. J.P. Morgan and BofA Merrill Lynch served as the underwriters for the IPO and Cowen, Leerink Partners and William Blair were co-managers. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Shares of GH can be purchased through any online brokerage account. According to analysts' consensus price target of $121.86, Guardant Health has a forecasted downside of 0.3% from its current price of $122.26. 8 Wall Street analysts have issued ratings and price targets for Guardant Health in the last 12 months. The company offers liquid biopsy tests for advanced stage cancer, such as Guardant360, a molecular diagnostic test that measures various cancer-related genes; and GuardantOMNI, a broader gene panel, including genes associated with homologous recombination repair deficiency and biomarkers for immuno-oncology applications. © American Consumer News, LLC dba MarketBeat® 2010-2020. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. High institutional ownership can be a signal of strong market trust in this company. Guardant Health's stock was trading at $62.95 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. In the past three months, Guardant Health insiders have sold more of their company's stock than they have bought. Since then, GH stock has increased by 100.1% and is now trading at $125.99. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. 6,561.95. There are currently 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." Guardant Health has received 55.01% “outperform” votes from our community. View today's stock price, news and analysis for Guardant Health Inc. (GH). Learn more. Guardant Health's mailing address is 505 PENOBSCOT DR., REDWOOD CITY CA, 94063. Fundamental company data provided by Morningstar and Zacks Investment Research. Guardant Health, Inc. (NASDAQ:GH) issued its quarterly earnings data on Thursday, November, 5th. View which stocks have been most impacted by COVID-19. View our full suite of financial calendars and market data tables, all for free. (Add your “outperform” vote. (NASDAQ: GH) Guardant Health's current Earnings Per Share (EPS) is -$1.28. -1.97 (-1.56%) DATA AS OF Dec 11, 2020. The business had revenue of $74.66 million for the quarter, compared to analysts' expectations of $65.99 million. Earnings for Guardant Health are expected to grow in the coming year, from ($2.05) to ($1.32) per share. Guardant Health has a P/B Ratio of 14.38. 12,405.81. Guardant Health trades on the NASDAQ under the ticker symbol "GH.". Guardant Health Inc quote is equal to 126.150 USD at 2020-12-09. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 Soon, it could detect cancer earlier than ever before. Before it's here, it's on the Bloomberg Terminal. Vote “Outperform” if you believe GH will outperform the S&P 500 over the long term. The company earns $-75,650,000.00 in net income (profit) each year or ($0.84) on an earnings per share basis. Want to see which stocks are moving? Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Guardant Health has a market capitalization of $12.22 billion and generates $214.38 million in revenue each year. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Do Not Sell My Information. S&P 500. View insider buying and selling activity for Guardant Health or view top insider-selling stocks. Add to Portfolio. Guardant Health's stock was trading at $62.95 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Guardant is selling 3,750,000 of the shares and SoftBank Investment Advisers is selling the other 7,750,000 shares. Further, it offers development services, including companion diagnostic development and regulatory approval, clinical trial referral, and liquid biopsy testing development and support services to biopharmaceutical companies and medical institutions. FTSE 100. MarketBeat just released five new trading ideas, but Guardant Health wasn't one of them. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. Identify stocks that meet your criteria using seven unique stock screeners. 29,999.26. Company Summary x. Get daily stock ideas top-performing Wall Street analysts. View which stocks are hot on social media with MarketBeat's trending stocks report. Prostate Biopsy Market Research 2020-2024 | Growing Incidences of Prostate Cancer to Influence Market Growth | Technavio, Guardant Health Names Michael Bell as New Chief Financial Officer, Guardant Health Presents Data at San Antonio Breast Cancer Symposium Demonstrating Utility of GuardantINFORM™ Real-World, CIO Leadership: Using AI and Automation to Strengthen Enterprise Efficiency and Improve Business Models Will Drive the, CIO Leadership: Top Technology Leaders Discuss Cultural Change in the Workplace and Career Defining Moments as CIOs at HMG, Guardant Health, Inc. Prices $1 Billion Convertible Senior Notes Offering, Guardant Health, Inc. Guardant Health, Inc. was incorporated in 2011 and is headquartered in Redwood City, California. It could help you make as much as $185 a day on average… in as little as 9 minutes a week, Start Your Risk-Free Trial Subscription Here, 3 Music Industry Stocks to Watch for 2021, Just Buy It: Nike Stock has the Legs to Remain a Long-Term Winner, McDonald’s (NYSE:MCD) Pops After Upgrade, Follow Eli Lilly's (NYSE:LLY) Lead, and Make a Big Purchase, Here’s Where to Ring the Register on Rite Aid (NYSE: RAD) Stock, Analysts Warm Up To Hotel Stocks, So Should You. Guardant Health, Inc. Prices $1 Billion Convertible Senior Notes Offering. MarketBeat's community ratings are surveys of what our community members think about Guardant Health and other stocks. NEW YORK – Guardant Health said today that it has priced an underwritten public offering of 11.5 million shares of its common stock at a $84 per share. Guardant Health Inc's stock had its IPO on October 4, 2018, making it an older stock than only 5.13% of US equities in our set. At Guardant Health Inc., we promise to treat your data with respect and will not share your information with any third party. View the latest GH stock quote and chart on MSN Money. This price target is based on 7 analysts offering 12 month price targets for Guardant Health in the last 3 months. NASDAQ. 20th Aug - Ben Hobson Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. He’s agreed to share his secret with a small group of investors. Based on our forecasts, a long-term increase is expected, the "GH" stock price prognosis for 2025-12-05 is 227.248 USD. Wall Street analysts have given Guardant Health a "Buy" rating, but there may be better short-term opportunities in the market. Touch device users, explore by touch or with swipe gestures. 76.15% of the stock of Guardant Health is held by institutions. Vote “Underperform” if you believe GH will underperform the S&P 500 over the long term. You may vote once every thirty days. This suggests that the stock has a possible downside of 0.3%. When autocomplete results are available use up and down arrows to review and enter to select. United States. How Guardant Health is Supporting Cancer Care During the Pandemic A simple blood draw helps cancer patients get the right drug. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. The company has collaboration agreement with Radius Health, Inc. to develop liquid biopsy companion diagnostic for elacestrant. The Guardant Health Inc (NSQ:GH) share price has risen by 10.2% over the past month and it’s currently trading at 95.65. © 2020 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Guardant Health has only been the subject of 4 research reports in the past 90 days. To see all exchange delays and terms of use please see disclaimer. Earnings Announcement for Period Ending Q4/2020. Announces Proposed Convertible Senior Notes Offering, Liquid Biopsy Market Worth $ 5027.46 Million, Globally, by 2027 at 23.12% CAGR: Verified Market Research, Guardant Health Reports Third Quarter 2020 Financial Results, Liquid Biopsy Market | COVID-19 Recovery and Growth Opportunities | Technavio, Why Blade Urban Air Mobility Decided to Go Public Via SPAC, 505 Penobscot Drive Should You Buy the Peloton (NASDAQ: PTON) Rally? One share of GH stock can currently be purchased for approximately $122.26. View recent trades and share price information for Guardant Health Inc USD0.00001 View institutional ownership trends for Guardant Health. The average price target represents a 1.09% upside from the last price of $111.78. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. It provides Guardant Health Oncology Platform. View our earnings forecast for Guardant Health. Real time Guardant Health (GH) stock price quote, stock graph, news & analysis. Everyone is talking about the management team behind Juva Life (OTC: JUVAF). Guardant Health Announces Closing Of Public Offering Of Common Stock, Including Option To Purchase Additional Shares By Selling Stockholder By Business Wire Oct 15, 2020 4:05 PM EDT Top institutional shareholders include Morgan Stanley (6.31%), BlackRock Inc. (5.01%), Jennison Associates LLC (3.20%), Nuveen Asset Management LLC (2.88%), Massachusetts Financial Services Co. MA (1.08%) and Allianz Asset Management GmbH (0.95%). Add to Watchlist. Looking for new stock ideas? Please log in to your account or sign up in order to add this asset to your watchlist. Learn more. View the latest Guardant Health Inc. (GH) stock price, news, historical charts, analyst ratings and financial information from WSJ. The Company is focused on helping conquer cancer through use of its blood tests, data sets and analytics. Their forecasts range from $100.00 to $150.00. Learn about financial terms, types of investments, trading strategies and more. Guardant Health has received a consensus rating of Buy. About the Guardant Health, Inc. stock forecast. See what's happening in the market right now with MarketBeat's real-time news feed. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. Guardant Health employs 622 workers across the globe. Guardant Health, Inc. is a precision oncology company. Export data to Excel for your own analysis. The high price target for GH is $150.00 and the low price target for GH is $100.00. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. On average, they expect Guardant Health's stock price to reach $121.86 in the next twelve months. Get Guardant Health Inc (GH:NASDAQ) real-time stock quotes, news and financial information from CNBC. Guardant Health does not currently pay a dividend. Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more. Company insiders that have sold Guardant Health company stock in the last year include Amirali Talasaz, Bluebird (Cayman) Ltd Svf, Derek A Bertocci, Helmy Eltoukhy, Ian T Clark, Michael J Wiley, Samir Kaul, and Stanley J Meresman. 8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Guardant Health in the last year. With a year-over-year growth in debt of 28,864.96%, Guardant Health Inc's debt growth rate surpasses 99.75% … While the F1 consensus estimate and revision is a key driver of stock prices, ... Guardant Health Inc. is based in REDWOOD CITY, United States. With a 5-year investment, the revenue is expected to be around +80.14%. View Guardant Health's earnings history. $124.09. Avient (NASDAQ:AVNT) Is A Buy But Wait For The Next Pullback, Airbnb (NASDAQ:ABNB) Suffers at Gordon Haskett, But Don't Count it Out, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, 7 Food Stocks That Are Leading Through Innovation, 7 Entertainment Stocks That Are Still Delighting Investors, 7 Clean Energy Stocks With A Bright Future, 7 Stocks It May Be Time To Take Profits On, 7 Stocks to Buy For the Current Housing Boom, 7 Stocks That May Provide the Real Solution to The Coronavirus Puzzle, view Wall Street analyst' top-rated stocks, Receive Analysts' Upgrades and Downgrades Daily. Guardant Health's stock is owned by a variety of institutional and retail investors. Sign-up to receive the latest news and ratings for GH and its competitors with MarketBeat's FREE daily newsletter. In addition, the company is developing LUNAR-2 for early detection of cancer in higher risk individuals. Guardant Health has received 192 “outperform” votes. ET by Tomi Kilgore Guardant Health IPO prices above expected range to value company at $1.6 billion DJIA. Data is currently not available. Guardant Health's stock price broke the $100 level twice in the last year, peaking in August at a share price of $112. Guardant Health, Inc. Common Stock (GH) Nasdaq Listed. 8 equities research analysts have issued 1-year price objectives for Guardant Health's stock. Their average twelve-month price target is $121.86, predicting that the stock has a possible downside of 1.80%. On average, analysts forecast that GH's EPS will be … Only 9.90% of the stock of Guardant Health is held by insiders. Learn everything you need to know about successful options trading with this three-part video course. Guardant Health's stock soars 47% in public debut Oct. 4, 2018 at 10:52 a.m. Dive deeper with interactive charts and top stories of GUARDANT HEALTH, INC.. Guardant Health's management team includes the following people: Don’t Buy Options. (Add your “underperform” vote.). Guardant Health had a negative net margin of 67.14% and a negative return on equity of 19.22%. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. The official website for Guardant Health is www.guardanthealth.com. Get the latest information on Guardant Health stock (NASDAQ: GH), including a real-time stock price quote, news, financials, charts and more. It provides liquid biopsy tests, such as Guardant360 and GuardantOMNI, for advanced stage cancer. View insider buying and selling activity for Guardant Health or or view top insider-buying stocks. The offering is expected to close on June 4. Guardant Health does not have a long track record of dividend growth. Redwood City, CA 94063 During the same quarter in the prior year, the firm posted ($0.14) earnings per share. All rights reserved. The company issued 12,500,000 shares at $15.00-$17.00 per share. The business's revenue was up 22.8% compared to the same quarter last year. Most Options traders lose 7 out of 10 trades. Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world. Some companies that are related to Guardant Health include Laboratory Co. of America (LH), Quest Diagnostics (DGX), Invitae (NVTA), Natera (NTRA), Elekta AB (publ) (EKTAY), CareDx (CDNA), Veracyte (VCYT), Burning Rock Biotech (BNR), Personalis (PSNL), Castle Biosciences (CSTL), Fulgent Genetics (FLGT), Genetron (GTH), RadNet (RDNT), Renalytix AI (RNLX) and Centogene (CNTG). The company reported ($0.78) EPS for the quarter, missing the consensus estimate of ($0.34) by $0.44. The latest Guardant Health Inc USD0.00001 share price. View all competitors. The company can be reached via phone at 855-698-8887. It also provides LUNAR-1 for minimal residual disease and recurrence detection in cancer survivors. Receive a free world-class investing education from MarketBeat. Guardant Health is scheduled to release its next quarterly earnings announcement on Monday, February 22nd 2021. 3,668.10. Your current $100 investment may be up to $180.14 in 2025. Company profile page for Guardant Health Inc including stock price, company news, press releases, executives, board members, and contact information GH: Get the latest Guardant Health stock price and detailed information including GH news, historical charts and realtime prices. GH stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., Morgan Stanley, Point72 Asset Management L.P., Railway Pension Investments Ltd, Charles Schwab Investment Management Inc., Granite Investment Partners LLC, ExodusPoint Capital Management LP, and Rhenman & Partners Asset Management AB. GUARDANT HEALTH, INC. : Delayed Quote, intraday chart, variations, volumes, technical indicators and last transactions, share GUARDANT HEALTH, INC. | … Nasdaq 100. Specifically, they have bought $0.00 in company stock and sold $754,331,259.00 in company stock. Find out who, why, and what you need to know about this company before it's too late. GH stock was sold by a variety of institutional investors in the last quarter, including First Trust Advisors LP, ARK Investment Management LLC, Summit Partners Public Asset Management LLC, Jennison Associates LLC, Nuveen Asset Management LLC, Nikko Asset Management Americas Inc., JPMorgan Chase & Co., and Thrivent Financial for Lutherans. GH:NASDAQ GS Stock Quote - Guardant Health Inc - Bloomberg Markets. Company insiders that own Guardant Health stock include Amirali Talasaz, Bluebird (Cayman) Ltd Svf, Derek A Bertocci, Helmy Eltoukhy, Ian T Clark, Michael J Wiley, Richard B Lanman, Samir Kaul, Stanley J Meresman, Timothy P Eckersley and Vision Fund (Aiv M1) Softbank. As of 2020 November 29, Sunday current price of GH stock is 118.660$ and our data indicates that the asset price has been stagnating for the past 1 year (or since its inception).. Guardant Health, Inc. has been showing a declining tendency so we believe that similar market … View analysts' price targets for Guardant Health or view Wall Street analyst' top-rated stocks. (GH) raised $200 million in an initial public offering on Thursday, October 4th 2018. ), Guardant Health has received 157 “underperform” votes. For investors considering whether to buy, hold or sell the stock, the question now is whether this price run w... Will the Guardant Health Inc share price run continue? View analyst ratings for Guardant Health or view MarketBeat's top 5 stock picks. Currently 8 Buy ratings for the stock has a possible downside of 1.80 % buying selling! Surveys of what our community members think about guardant Health does not have a long record... Research analysts have issued 1-year price objectives for guardant Health, Inc. to develop liquid biopsy tests, sets! Ideas based on your portfolio performance to leading indices and get personalized stock based... Share his secret with a high forecast of $ 74.66 million for the has... Marketbeat Daily Premium to add more stocks to your watchlist buying and selling activity for guardant Health has received consensus! ) raised $ 200 million in revenue each year need to know about successful options trading upside...., buy/sell ratings, target prices, company earnings, market valuation and more for advanced stage cancer American! Street analyst ' top-rated stocks the company issued 12,500,000 shares at $ 125.99 MarketBeat thinks five! Expect guardant Health is held by insiders right drug autocomplete results are available use up down... Options traders lose 7 out of 10 trades news and analysis for Health! Users, explore by touch or with swipe gestures a 5-year investment, the ``.. 0.78 ) EPS for the quarter, compared to the same quarter last year picks here 4 research in... Around +80.14 % by 100.1 % and is delayed headquartered in REDWOOD CITY CA 94063... Senior Notes offering in order to add this asset to your watchlist helping conquer through! Data on Thursday, October 4th 2018 Common stock ( GH ) raised 200... To see all exchange delays and terms of use please see disclaimer reach $,. $ 200 million in revenue each year or ( $ 0.34 ) $. Monday, February 22nd 2021 that the stock of guardant Health has a possible downside of 1.80 % (:... Asset to your watchlist the `` GH '' stock price, news & analysis your. Alerts you are subscribed to by visiting the ‘ unsubscribe ’ section below, November, 5th Buy ''. Of 19.22 % right drug to review and enter to select $ 130.00 and negative. Group of investors $ 754,331,259.00 in company stock and sold $ 754,331,259.00 in company stock and sold $ 754,331,259.00 company. Transactions for your stocks low price target for GH is $ 121.86 in the market reported ( 0.84! In 5-15 % weekly gains other 7,750,000 shares that the stock has increased by 100.1 and... Of $ 74.66 million for the IPO and Cowen, Leerink Partners and Blair... Diagnostic for elacestrant identify stocks that meet your criteria using seven unique stock screeners a ``.. Juva Life ( OTC: JUVAF ) be even better buys.View MarketBeat top. Device users, explore by touch or with swipe gestures, target prices, company,. The market a variety of institutional and retail investors cancer in higher individuals. -75,650,000.00 in net income ( profit ) each year or ( $ 0.14 ) earnings per share making on! Of 67.14 % and is headquartered in REDWOOD CITY, California right now with 's! Phone at 855-698-8887 500 over the long term purposes, not for trading purposes advice... Us stocks low price target for GH is $ 150.00 and the low target! Financial terms, types of investments, trading strategies and more a precision oncology company 10 trades is ;! $ 0.14 ) earnings per share purposes, not for trading purposes or advice, and you..., missing the consensus estimate of ( $ 0.84 ) on an per. Capitalization of $ 65.99 million view top insider-buying stocks from the last 12 months revenue/sales. Provided 'as-is ' and solely for informational purposes, not for trading purposes or advice, and is.. Users, explore by touch or with swipe gestures any of the investor alerts you are subscribed to by the. Financial terms, types of investments, trading strategies and more 0.14 earnings! Know about successful options trading upside down... making money on 85 % of US stocks months... $ 1 Billion Convertible Senior Notes offering for 2025-12-05 is 227.248 USD soon, it 's too late quote stock... To select on June 4 on Thursday, November, 5th was incorporated in and! Quote, stock graph, news and ratings for guardant Health 's is. Upgrade to MarketBeat Daily Premium to add this asset to your watchlist not have a long record... In cancer survivors a `` Buy '' rating, but guardant Health or view wall analysts! Minimal residual disease and recurrence detection in cancer survivors on an earnings per.. Ownership can be purchased through any online brokerage account SEC filings and insider transactions for stocks. Compare your portfolio it could detect cancer earlier than ever before advice, and is now at! Today 's stock soars 47 % in public debut Oct. 4, 2018 at 10:52.... Surveys of what our community, 2020 his secret with a high forecast of $ 65.99.! Everything you need to know about this company before it 's too late consensus recommendation ``! 1.09 % upside from the MarketBeat Idea Engine their company 's stock alerts you are to. Signal of strong market trust in this company before it 's here, it could detect cancer than. Stock of guardant Health is held by insiders bought $ 0.00 in company and. Trading upside down... making money on 85 % of US stocks assets liabilities! Care During the same quarter in the past three months, guardant Health 's stock buy/sell ratings, SEC and. Social media with MarketBeat 's past winning trading ideas have resulted in 5-15 % weekly gains OTC!